Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
AMGEN INC
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-49.6% vs price
Base Case (Median)
-35.3% vs price
Bull Case (75th pct.)
9.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $954.44 | 112.1% | High (40%) |
| PE Comparable | $365.73 | -18.7% | Medium (25%) |
| Growth Trajectory DCF | $619.39 | 37.7% | Medium (20%) |
| Graham Number | $76.19 | -83.1% | Medium (40%) |
| EV/EBITDA | $227.17 | -49.5% | Medium (20%) |
| EV/FCF | $291.10 | -35.3% | Medium (20%) |
| Earnings Power Value | $226.05 | -49.8% | Medium (50%) |
Based on 7 out of 7 methods, AMGN appears fairly valued at the current price of $449.90. The base case fair value of $291.10 implies 35.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.